Cargando…

Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis

Background and purpose: Stroke is a leading cause of death and acquired disability in adults today. Inflammation plays an important role in the pathophysiology of stroke. The peripheral neutrophil-to-lymphocyte ratio (NLR) is an important global inflammatory indicator becoming more mainstream in str...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Si-Ying, Zhao, Xiao-Xi, Rajah, Gary, Hua, Chang, Kang, Rui-jun, Han, Yi-peng, Ding, Yu-chuan, Meng, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787274/
https://www.ncbi.nlm.nih.gov/pubmed/31636598
http://dx.doi.org/10.3389/fneur.2019.01032
_version_ 1783458231715102720
author Song, Si-Ying
Zhao, Xiao-Xi
Rajah, Gary
Hua, Chang
Kang, Rui-jun
Han, Yi-peng
Ding, Yu-chuan
Meng, Ran
author_facet Song, Si-Ying
Zhao, Xiao-Xi
Rajah, Gary
Hua, Chang
Kang, Rui-jun
Han, Yi-peng
Ding, Yu-chuan
Meng, Ran
author_sort Song, Si-Ying
collection PubMed
description Background and purpose: Stroke is a leading cause of death and acquired disability in adults today. Inflammation plays an important role in the pathophysiology of stroke. The peripheral neutrophil-to-lymphocyte ratio (NLR) is an important global inflammatory indicator becoming more mainstream in stroke care. This meta-analysis aims to evaluate the relationship between the baseline NLR and acute ischemic and hemorrhagic stroke, as well as define the clinical significance of NLR in subtypes of ischemic stroke. Methods: This meta-analysis was registered in PROSPERO with the number CRD42018105305. We went through relevant articles from PubMed Central (PMC) and EMBASE. Prospective and retrospective studies were included if related to baseline NLR levels prior to treatment in patients with ischemic or hemorrhagic stroke. Studies were identified up until April 2019. The cutoff value for NLR and the sources of odds ratios (ORs)/risk ratios (RRs) were measured. Modified Rankin Scale (mRS) was used to investigate the outcomes during clinical follow-up. Predefined criteria were used to evaluate the risk of bias in eligible studies. P-values < 0.05 were considered statistically significant. STATA version 14.0 (STATA, College Station, TX) was used in all statistical analyses. Results: Thirty-seven studies with 43,979 individuals were included in the final analysis. Higher NLR levels were correlated with increased risk of ischemic stroke (ORs/RRs = 1.609; 95% CI = 1.283–2.019), unfavorable functional outcome at 3 months (ORs/RRs = 1.851; 95% CI = 1.325–2.584), and increased mortality in patients with ischemic stroke (ORs/RRs = 1.068; 95% CI = 1.027–1.111). While in terms of hemorrhagic stroke (including SAH and ICH), elevated NLR levels only had deleterious effects on mortality (ORs/RRs = 1.080; 95% CI = 1.018–1.146). Conclusions: Baseline NLR level is a promising predictor of the clinical outcomes in both ischemic and hemorrhagic stroke. In addition, elevated NLR is also associated with a high risk of ischemic stroke occurrence. However, future studies are needed to demonstrate the underlying mechanisms and further explain this association.
format Online
Article
Text
id pubmed-6787274
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67872742019-10-21 Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis Song, Si-Ying Zhao, Xiao-Xi Rajah, Gary Hua, Chang Kang, Rui-jun Han, Yi-peng Ding, Yu-chuan Meng, Ran Front Neurol Neurology Background and purpose: Stroke is a leading cause of death and acquired disability in adults today. Inflammation plays an important role in the pathophysiology of stroke. The peripheral neutrophil-to-lymphocyte ratio (NLR) is an important global inflammatory indicator becoming more mainstream in stroke care. This meta-analysis aims to evaluate the relationship between the baseline NLR and acute ischemic and hemorrhagic stroke, as well as define the clinical significance of NLR in subtypes of ischemic stroke. Methods: This meta-analysis was registered in PROSPERO with the number CRD42018105305. We went through relevant articles from PubMed Central (PMC) and EMBASE. Prospective and retrospective studies were included if related to baseline NLR levels prior to treatment in patients with ischemic or hemorrhagic stroke. Studies were identified up until April 2019. The cutoff value for NLR and the sources of odds ratios (ORs)/risk ratios (RRs) were measured. Modified Rankin Scale (mRS) was used to investigate the outcomes during clinical follow-up. Predefined criteria were used to evaluate the risk of bias in eligible studies. P-values < 0.05 were considered statistically significant. STATA version 14.0 (STATA, College Station, TX) was used in all statistical analyses. Results: Thirty-seven studies with 43,979 individuals were included in the final analysis. Higher NLR levels were correlated with increased risk of ischemic stroke (ORs/RRs = 1.609; 95% CI = 1.283–2.019), unfavorable functional outcome at 3 months (ORs/RRs = 1.851; 95% CI = 1.325–2.584), and increased mortality in patients with ischemic stroke (ORs/RRs = 1.068; 95% CI = 1.027–1.111). While in terms of hemorrhagic stroke (including SAH and ICH), elevated NLR levels only had deleterious effects on mortality (ORs/RRs = 1.080; 95% CI = 1.018–1.146). Conclusions: Baseline NLR level is a promising predictor of the clinical outcomes in both ischemic and hemorrhagic stroke. In addition, elevated NLR is also associated with a high risk of ischemic stroke occurrence. However, future studies are needed to demonstrate the underlying mechanisms and further explain this association. Frontiers Media S.A. 2019-10-04 /pmc/articles/PMC6787274/ /pubmed/31636598 http://dx.doi.org/10.3389/fneur.2019.01032 Text en Copyright © 2019 Song, Zhao, Rajah, Hua, Kang, Han, Ding and Meng. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Song, Si-Ying
Zhao, Xiao-Xi
Rajah, Gary
Hua, Chang
Kang, Rui-jun
Han, Yi-peng
Ding, Yu-chuan
Meng, Ran
Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis
title Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis
title_full Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis
title_fullStr Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis
title_full_unstemmed Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis
title_short Clinical Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Patients With Ischemic Stroke or Hemorrhagic Stroke: An Updated Meta-Analysis
title_sort clinical significance of baseline neutrophil-to-lymphocyte ratio in patients with ischemic stroke or hemorrhagic stroke: an updated meta-analysis
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787274/
https://www.ncbi.nlm.nih.gov/pubmed/31636598
http://dx.doi.org/10.3389/fneur.2019.01032
work_keys_str_mv AT songsiying clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT zhaoxiaoxi clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT rajahgary clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT huachang clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT kangruijun clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT hanyipeng clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT dingyuchuan clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis
AT mengran clinicalsignificanceofbaselineneutrophiltolymphocyteratioinpatientswithischemicstrokeorhemorrhagicstrokeanupdatedmetaanalysis